Tesamorelin + Ipamorelin 11mg/6mg (17mg)
This ≥98% purity research blend combines tesamorelin (11 mg), a growth hormone-releasing hormone analog, with ipamorelin (6 mg), a selective ghrelin-receptor agonist. Supplied as a lyophilized powder, it is intended solely for laboratory investigation of growth-hormone secretagogue and receptor-signaling pathways.
Availability: Only 20 left in stock
Product Description
Overview
Tesamorelin + Ipamorelin is a two-component research blend containing 11 mg tesamorelin and 6 mg ipamorelin per vial (17 mg total). The material is supplied as a ≥98% purity lyophilized powder for laboratory research.
Mechanism of Action
Tesamorelin is a growth hormone-releasing hormone (GHRH) analog investigated for its interaction with GHRH receptor signaling. Ipamorelin is a selective growth hormone secretagogue investigated for ghrelin-receptor activity. Together, these compounds support in vitro and analytical research on peptide signaling and secretagogue-response pathways; no outcome or clinical application is represented.
Molecular Info
- Tesamorelin CAS Number: 218949-48-5
- Tesamorelin Molecular Formula: C221H366N72O67S
- Tesamorelin Molecular Weight: approximately 5135.9 g/mol
- Ipamorelin CAS Number: 170851-70-4
- Ipamorelin Molecular Formula: C38H49N9O5
- Ipamorelin Molecular Weight: approximately 711.85 g/mol
- Form: Lyophilized powder
- Purity: ≥98%
- Contents: Tesamorelin 11 mg + Ipamorelin 6 mg per vial
Handling & Storage
Store unopened vials at 2–8°C. Keep tightly closed and protect from light and moisture. Use only appropriate laboratory handling procedures.
For Research Use Only
This product is supplied solely for laboratory and research use. It is not for human or veterinary use and is not intended for diagnosis, treatment, cure, or prevention of any disease. No dosing, administration, or clinical-use guidance is provided.
